|
|
|
TXG - 10x Genomics, Inc
10x Genomics Inc (TXG) is a biotechnology company that provides solutions for the analysis of biological systems at a resolution and scale that matches the complexity of biology. The company's products and services enable researchers to study genomic, transcriptomic, and proteomic information from a single cell, and to reconstruct the spatial and molecular context of biology.
10x Genomics was founded in 2012 and is based in Pleasanton, California. The company's products are used in academic research, pharmaceutical drug discovery, and clinical research. Its technology is based on a proprietary microfluidics platform that allows for the analysis of large numbers of individual cells in parallel.
In addition to its single-cell analysis products, 10x Genomics also offers products and services for the analysis of gene expression, immune profiling, and spatial genomics. Its customers include academic research institutions, pharmaceutical companies, and clinical research organizations. As of September 2021, the company had a market capitalization of over $15 billion.
|
|
|
|
|
